Bicycle therapeutics plc - expects to initiate a phase iia clinical trial of its bt1718 product candidate

Bicycle therapeutics plc - expects to initiate a phase iia clinical trial of its bt1718 product candidate in 2020.bicycle therapeutics plc - expects to provide interim data regarding its phase i clinical trial of bt5528 in 2020.bicycle therapeutics - expects to provide interim data regarding phase i clinical trial of bt5528, initial a phase i clinical trial of bt8009 in 2020.bicycle therapeutics plc - expects to advance investigational new drug application enabling activities regarding bt7480 in 2020.
BCYC Ratings Summary
BCYC Quant Ranking